Corcept Therapeutics Incorporated
Methods for Imaging and Treatment of Somatostatin-Receptor Positive Tumors

Last updated:

Abstract:

Methods for treating, identifying and localizing tumors expressing somatostatin receptors (SRs), including methods of enhancing the efficacy of imaging techniques by administration of a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator (HKGRM) effective to increase SR expression in tumors. HKGRM administration for enhancing SR-based tumor imaging and treating neuroendocrine tumors. HKGRM and somatostatin or somatostatin analog combination therapy for treating and enhancing SR-based tumor imaging.

Status:
Application
Type:

Utility

Filling date:

19 Dec 2019

Issue date:

3 Mar 2022